Literature DB >> 10435166

Gynaecological cancer.

H C Kitchener1.   

Abstract

Gynaecological cancer encompasses a number of tumours with different epidemiology, pathology and treatment strategies. This article reviews the principal clinical advances and areas of development in cancer of the ovary, cervix, endometrium and vulva.

Entities:  

Mesh：

Year:  1999        PMID： 10435166      PMCID： PMC1741248          DOI： 10.1136/pgmj.75.884.332

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  18 in total

Review 1.  The performance of screening tests for ovarian cancer: results of a systematic review.

Authors:  R Bell; M Petticrew; T Sheldon
Journal:  Br J Obstet Gynaecol       Date:  1998-11

2.  Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Authors:  I Jacobs; A P Davies; J Bridges; I Stabile; T Fay; A Lower; J G Grudzinskas; D Oram
Journal:  BMJ       Date:  1993-04-17

3.  Individualization of treatment for stage I squamous cell vulvar carcinoma.

Authors:  N F Hacker; J S Berek; L D Lagasse; R K Nieberg; R S Leuchter
Journal:  Obstet Gynecol       Date:  1984-02       Impact factor: 7.661

4.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

5.  Ovarian cancer screening in asymptomatic postmenopausal women.

Authors:  P D DePriest; J R van Nagell; H H Gallion; D Shenson; J E Hunter; S J Andrews; D E Powell; E J Pavlik
Journal:  Gynecol Oncol       Date:  1993-11       Impact factor: 5.482

6.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

7.  Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis?

Authors:  R W Hunter; N D Alexander; W P Soutter
Journal:  Am J Obstet Gynecol       Date:  1992-02       Impact factor: 8.661

8.  Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling.

Authors:  L C Kilgore; E E Partridge; R D Alvarez; J M Austin; H M Shingleton; F Noojin; W Conner
Journal:  Gynecol Oncol       Date:  1995-01       Impact factor: 5.482

9.  Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients.

Authors:  J Aalders; V Abeler; P Kolstad; M Onsrud
Journal:  Obstet Gynecol       Date:  1980-10       Impact factor: 7.661

10.  Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.

Authors:  J P Neijt; W W ten Bokkel Huinink; M E van der Burg; A T van Oosterom; P H Willemse; J B Vermorken; A C van Lindert; A P Heintz; E Aartsen; M van Lent
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.